Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Terrana Biosciences
Cambridge, Massachusetts, United Statesterranabio.com ↗
- Ownership
- Private
- Employees
- ~7
- Development stage
- Preclinical
01
Overview
Terrana Biosciences develops transformative therapeutics and technologies targeting neurological and psychiatric diseases. Its portfolio includes late-stage drug candidates such as TerXT—a novel combination of xanomeline and trospium prodrugs for schizophrenia—and Idazoxan XR, an extended-release alpha2 adrenergic antagonist with demonstrated efficacy in Phase II studies. The company also holds exclusive rights to two late-stage CNS assets from Sanofi, including tolebrutinib. Additionally, Terrana has developed NM‑101, the world’s first FDA-cleared cloud-based software platform for neuromelanin MRI analysis[5][7][9].
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small moleculesProdrugsAI-enabled software as a medical device (for imaging)
- Industry
- Biotech
02
Partnerships
Sanofi S.A. – exclusive worldwide rights to two late-stage CNS pipeline assets[7][10]Pierre Fabre – exclusive license for Idazoxan XR global development/commercialization rights[5]Blumentech – acquired full patent portfolio related to psychedelics research by Jordi Riba Serrano[7]
Beyond the preview
Go deeper on Terrana Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Terrana Biosciences.